ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2081

Synovial Fluid Leukocyte Count and Its Association with Crystal Deposition in Asymptomatic Hyperuricemia

Mariano Andrés1,2, José Antonio Bernal3, María Dolores Arenas4 and Eliseo Pascual1,5, 1Sección de Reumatología, Hospital General Universitario de Alicante, Alicante, Spain, 2Departamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain, 3Reumatología, Hospital Universitario del Vinalopó, Elche, Spain, 4Unidad de Nefrología, Hospital Vithas Perpetuo Socorro, Alicante, Spain, 5Emeritus Professor, Universidad Miguel Hernández, Elche, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Crystal-induced arthritis, hyperuricemia, inflammation and synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Metabolic and Crystal Arthropathies Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Articular and periarticular deposits of monosodium urate (MSU) crystals in asymptomatic hyperuricemia (AH) may associate with more severe forms of atherosclerosis [Andrés 2016]. This likely relates with crystal-driven subclinical inflammation, a phenomenon well described in gout [2] but to date not assessed in AH. The aim of the present study was to assess the synovial fluid (SF) leukocytes count in patients with AH depending on the presence of crystals.

Methods: Consecutive patients with AH were selected from nephrology clinics. Hyperuricemia threshold was established at serum uric acid (SUA) >=7mg/dL; those on current urate-lowering therapy were excluded. Ultrasound (US) of knees, ankles and first metatarsophalangeal joints was performed blinded to clinical and laboratory data, to perform US-guided aspiration and obtain SF samples. Samples were jointly analyzed in fresh by two observers, using a compensated polarized light microscope equipped with two viewing stations. The second observer was also unaware of US findings. The presence of leukocytes and crystals was established by consensus. SF leukocyte count was performed using a Neubauer counting camera. Mann-Whitney’s U and Kruskal-Wallis’ H were used for comparisons between groups.

Results: A total of 30 patients have been assessed, with SF samples available from 27 (three showed no joint effusion at US). Median age was 70 years (p25-75 59.8-75.5), and 16 of them (60%) were males. Median (p25-75) SUA and estimated glomerular filtration rate were 8.1 mg/dL (7.6-8.5) and 37.0 mL/min (31.0-47.5), respectively. Seven (25%) were on diuretics. After microscopy evaluation, MSU crystals were found in four patients (14.8%), calcium pyrophosphate (CPP) crystals in five (18.5%), and no crystals in 18 (66.7%). Groups were similar in SUA levels and renal function. Figure shows median leukocytes count according to crystal group: 200/mm3 (138-540) in MSU group; 60/mm3 (50-235) in CPP group; and 30/mm3 (10-53) in those with no crystal at SF. A statistically significant difference was found between the three groups (p=0.001), and comparing MSU crystals and no crystals groups (p<0.001); no difference was found between MSU and CPP groups, nor between CPP and no crystals groups.

Conclusion: MSU crystal deposition in patients with AH leads to higher SF leukocyte count, indicating low-grade inflammation. Despite low numbers, this significant finding adds evidence to the potential deleterious role of silent crystal deposits in AH patients.


Disclosure: M. Andrés, Grunenthal, 5; J. A. Bernal, None; M. D. Arenas, None; E. Pascual, AstraZeneca, 5,Grunenthal, 5.

To cite this abstract in AMA style:

Andrés M, Bernal JA, Arenas MD, Pascual E. Synovial Fluid Leukocyte Count and Its Association with Crystal Deposition in Asymptomatic Hyperuricemia [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/synovial-fluid-leukocyte-count-and-its-association-with-crystal-deposition-in-asymptomatic-hyperuricemia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-fluid-leukocyte-count-and-its-association-with-crystal-deposition-in-asymptomatic-hyperuricemia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology